The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKα/MMP9/TGF-β1/Smad pathway
Qixuan Huang, Jie Chen, Siqi Liao, Jiangchuan Long, Ronghua Fang, Yusen He, Pei‐Yun Chen, Dongfang Liu
Topics & Concepts
EmpagliflozinSMADSarcopeniaEndocrinologyInternal medicineSkeletal muscleFibrosisAMPKMedicineTransforming growth factorBiologyType 2 diabetesDiabetes mellitusCell biologyPhosphorylationProtein kinase ANutrition and Health in AgingMetabolism, Diabetes, and CancerParathyroid Disorders and Treatments